• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-杂芳基氟喹诺酮杂化物的化学合成与化疗潜力综述

A Comprehensive Review on Chemical Synthesis and Chemotherapeutic Potential of 3-Heteroaryl Fluoroquinolone Hybrids.

作者信息

Hryhoriv Halyna, Kovalenko Sergiy M, Georgiyants Marine, Sidorenko Lyudmila, Georgiyants Victoriya

机构信息

Pharmaceutical Chemistry Department, National University of Pharmacy, 61002 Kharkiv, Ukraine.

Organic Chemistry Department, Karazin National University, 61022 Kharkiv, Ukraine.

出版信息

Antibiotics (Basel). 2023 Mar 21;12(3):625. doi: 10.3390/antibiotics12030625.

DOI:10.3390/antibiotics12030625
PMID:36978492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045242/
Abstract

Fluoroquinolones have been studied for more than half a century. Since the 1960s, four generations of these synthetic antibiotics have been created and successfully introduced into clinical practice. However, they are still of interest for medicinal chemistry due to the wide possibilities for chemical modification, with subsequent useful changes in the pharmacokinetics and pharmacodynamics of the initial molecules. This review summarizes the chemical and pharmacological results of fluoroquinolones hybridization by introducing different heterocyclic moieties into position 3 of the core system. It analyses the synthetic procedures and approaches to the formation of heterocycles from the fluoroquinolone carboxyl group and reveals the most convenient ways for such procedures. Further, the results of biological activity investigations for the obtained hybrid pharmacophore systems are presented. The latter revealed numerous promising molecules that can be further studied to overcome the problem of resistance to antibiotics, to find novel anticancer agents and more.

摘要

氟喹诺酮类药物已经被研究了半个多世纪。自20世纪60年代以来,已经研发出四代这类合成抗生素,并成功应用于临床实践。然而,由于其在化学修饰方面具有广泛的可能性,能够对初始分子的药代动力学和药效学产生有益的后续变化,因此它们仍然是药物化学领域的研究热点。本综述总结了通过在核心体系的3位引入不同杂环部分实现氟喹诺酮类药物杂化的化学和药理学成果。分析了从氟喹诺酮羧基形成杂环的合成方法和途径,并揭示了此类过程最便捷的方法。此外,还介绍了所获得的杂化药效团系统的生物活性研究结果。后者揭示了众多有前景的分子,可进一步研究以克服抗生素耐药性问题、寻找新型抗癌药物等等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/12628c5a6404/antibiotics-12-00625-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/14fa7b2ac86a/antibiotics-12-00625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1e35ac6090b9/antibiotics-12-00625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1ba0a0f77e4d/antibiotics-12-00625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/aca47170026e/antibiotics-12-00625-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/bf16a08412b3/antibiotics-12-00625-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/78930d1cd373/antibiotics-12-00625-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/c1b90acaaada/antibiotics-12-00625-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/622fb623eb7d/antibiotics-12-00625-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1d463ceba4d9/antibiotics-12-00625-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/a9cb2b57afe1/antibiotics-12-00625-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/a5b71e905595/antibiotics-12-00625-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/fb8a5fbfc240/antibiotics-12-00625-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f3f1902b8092/antibiotics-12-00625-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/3acbafb3ed66/antibiotics-12-00625-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/502e25c369ef/antibiotics-12-00625-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d1c35490b67f/antibiotics-12-00625-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/9ce3096b5c1d/antibiotics-12-00625-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/fe381c1e08de/antibiotics-12-00625-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/9db221a1e629/antibiotics-12-00625-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4514fd66bd13/antibiotics-12-00625-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d82bcdfbe2f8/antibiotics-12-00625-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f3ec8af3ad6a/antibiotics-12-00625-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4ad90fc83194/antibiotics-12-00625-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f180c0514d50/antibiotics-12-00625-sch021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/23b36ffe0426/antibiotics-12-00625-sch022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/465abe0e474c/antibiotics-12-00625-sch023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/422a589a8f78/antibiotics-12-00625-sch024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/666704b0e947/antibiotics-12-00625-sch025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/44e9d0fda79f/antibiotics-12-00625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d8c0c437051d/antibiotics-12-00625-sch026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/47f093813964/antibiotics-12-00625-sch027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/19db9a11f67a/antibiotics-12-00625-sch028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4300745fab46/antibiotics-12-00625-sch029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/6d296fba876f/antibiotics-12-00625-sch030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/ea16eab77b93/antibiotics-12-00625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/46ca914d6370/antibiotics-12-00625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4cc9ab24e120/antibiotics-12-00625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/0436730a96ac/antibiotics-12-00625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/2ffdc60fc99c/antibiotics-12-00625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/12628c5a6404/antibiotics-12-00625-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/14fa7b2ac86a/antibiotics-12-00625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1e35ac6090b9/antibiotics-12-00625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1ba0a0f77e4d/antibiotics-12-00625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/aca47170026e/antibiotics-12-00625-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/bf16a08412b3/antibiotics-12-00625-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/78930d1cd373/antibiotics-12-00625-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/c1b90acaaada/antibiotics-12-00625-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/622fb623eb7d/antibiotics-12-00625-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/1d463ceba4d9/antibiotics-12-00625-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/a9cb2b57afe1/antibiotics-12-00625-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/a5b71e905595/antibiotics-12-00625-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/fb8a5fbfc240/antibiotics-12-00625-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f3f1902b8092/antibiotics-12-00625-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/3acbafb3ed66/antibiotics-12-00625-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/502e25c369ef/antibiotics-12-00625-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d1c35490b67f/antibiotics-12-00625-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/9ce3096b5c1d/antibiotics-12-00625-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/fe381c1e08de/antibiotics-12-00625-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/9db221a1e629/antibiotics-12-00625-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4514fd66bd13/antibiotics-12-00625-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d82bcdfbe2f8/antibiotics-12-00625-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f3ec8af3ad6a/antibiotics-12-00625-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4ad90fc83194/antibiotics-12-00625-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/f180c0514d50/antibiotics-12-00625-sch021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/23b36ffe0426/antibiotics-12-00625-sch022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/465abe0e474c/antibiotics-12-00625-sch023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/422a589a8f78/antibiotics-12-00625-sch024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/666704b0e947/antibiotics-12-00625-sch025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/44e9d0fda79f/antibiotics-12-00625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/d8c0c437051d/antibiotics-12-00625-sch026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/47f093813964/antibiotics-12-00625-sch027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/19db9a11f67a/antibiotics-12-00625-sch028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4300745fab46/antibiotics-12-00625-sch029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/6d296fba876f/antibiotics-12-00625-sch030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/ea16eab77b93/antibiotics-12-00625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/46ca914d6370/antibiotics-12-00625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/4cc9ab24e120/antibiotics-12-00625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/0436730a96ac/antibiotics-12-00625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/2ffdc60fc99c/antibiotics-12-00625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d160/10045242/12628c5a6404/antibiotics-12-00625-g010.jpg

相似文献

1
A Comprehensive Review on Chemical Synthesis and Chemotherapeutic Potential of 3-Heteroaryl Fluoroquinolone Hybrids.3-杂芳基氟喹诺酮杂化物的化学合成与化疗潜力综述
Antibiotics (Basel). 2023 Mar 21;12(3):625. doi: 10.3390/antibiotics12030625.
2
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.氟喹诺酮类杂化分子作为对抗抗菌耐药性的有前景的抗菌剂。
Pharmaceutics. 2022 Aug 22;14(8):1749. doi: 10.3390/pharmaceutics14081749.
3
Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.通过1,2,3-三唑连接的莫西沙星-异吲哚酮杂合物及其抗癌活性。
Curr Top Med Chem. 2020;20(16):1461-1467. doi: 10.2174/1568026620666200128144825.
4
Synthesis of Medicinally Privileged Heterocycles through Dielectric Heating.通过介电加热合成具有药用价值的杂环化合物。
Curr Med Chem. 2017;24(41):4596-4626. doi: 10.2174/0929867324666170223152137.
5
Advances in Spirocyclic Hybrids: Chemistry and Medicinal Actions.螺环杂合体的进展:化学与药用作用。
Curr Med Chem. 2018;25(31):3748-3767. doi: 10.2174/0929867325666180309124821.
6
Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.基于具有药理活性的吡唑/吡唑啉-噻唑烷杂化物的合成方法、构效关系及生物学应用
Eur J Med Chem. 2016 May 4;113:145-66. doi: 10.1016/j.ejmech.2016.02.030. Epub 2016 Feb 16.
7
Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.设计、合成及评估新型氟喹诺酮-黄酮杂合体作为对抗耐药微生物的强效抗生素。
Eur J Med Chem. 2014 Jun 10;80:92-100. doi: 10.1016/j.ejmech.2014.04.037. Epub 2014 Apr 13.
8
Fluoroquinolone-isatin hybrids and their biological activities.氟喹诺酮-靛红杂合体及其生物活性。
Eur J Med Chem. 2019 Jan 15;162:396-406. doi: 10.1016/j.ejmech.2018.11.032. Epub 2018 Nov 12.
9
Hybrid Molecules Containing Naphthoquinone and Quinolinedione Scaffolds as Antineoplastic Agents.含萘醌和喹喔啉二酮骨架的混合分子作为抗肿瘤药物。
Molecules. 2022 Aug 3;27(15):4948. doi: 10.3390/molecules27154948.
10
Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.具有治疗潜力的含杂环部分的五环三萜的半合成衍生物。
Molecules. 2022 Oct 3;27(19):6552. doi: 10.3390/molecules27196552.

引用本文的文献

1
[1,3]Thiazolo[3,2-b][1,2,4]triazolium Salts as Effective Antimicrobial Agents: Synthesis, Biological Activity Evaluation, and Molecular Docking Studies.[1,3]噻唑并[3,2-b][1,2,4]三唑鎓盐作为有效的抗菌剂:合成、生物活性评估及分子对接研究
Int J Mol Sci. 2025 Jul 16;26(14):6845. doi: 10.3390/ijms26146845.
2
The Rise, Fall, and Rethink of (Fluoro)quinolones: A Quick Rundown.(氟)喹诺酮类药物的兴衰与重新审视:简要概述
Pathogens. 2025 May 24;14(6):525. doi: 10.3390/pathogens14060525.
3
Quinolin-4-ones: Methods of Synthesis and Application in Medicine.

本文引用的文献

1
Novel heterocyclic 1,3,4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: Synthesis and computational molecular modeling.新型杂环 1,3,4-噁二唑类氟喹诺酮类衍生物作为一种有效的抗菌剂:合成与计算分子模拟。
Mol Divers. 2022 Jun;26(3):1581-1596. doi: 10.1007/s11030-021-10287-3. Epub 2021 Aug 2.
2
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.喹诺酮类药物:作用机制、致死性及其对抗生素耐药性的贡献。
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
3
Design, Synthesis and Pharmacological Evaluation of Some C Heterocyclic-Substituted Ciprofloxacin Derivatives as Chimeric Antitubercular Agents.
喹啉-4-酮:合成方法及其在医学中的应用
Molecules. 2025 Jan 3;30(1):163. doi: 10.3390/molecules30010163.
4
Novel quinolone substituted 1,3,4-oxadiazole derivatives: design, synthesis, antimicrobial and anti-inflammatory potential.新型喹诺酮取代的1,3,4-恶二唑衍生物:设计、合成、抗菌及抗炎潜力
Mol Divers. 2025 Jun;29(3):1911-1928. doi: 10.1007/s11030-024-10949-y. Epub 2024 Aug 3.
5
Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines.新型氟喹诺酮类药物对二维和三维人乳腺癌及膀胱癌细胞系的抗肿瘤作用机制
Cancers (Basel). 2024 Jun 14;16(12):2227. doi: 10.3390/cancers16122227.
6
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents.环丙沙星和诺氟沙星杂化化合物:潜在的抗癌药物。
Curr Top Med Chem. 2024;24(7):644-665. doi: 10.2174/0115680266288319240206052223.
一些 C 杂环取代的环丙沙星衍生物作为嵌合抗结核药物的设计、合成及药理学评价。
Chem Pharm Bull (Tokyo). 2020;68(12):1170-1177. doi: 10.1248/cpb.c20-00525.
4
Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.新型杂环氟喹诺酮柠檬酸盐缀合物作为拓扑异构酶IV潜在抑制剂的设计、合成及生物学评价:一项计算分子模拟研究
Curr Drug Discov Technol. 2021;18(6):e130921187682. doi: 10.2174/1570163817666201106143557.
5
Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids.新型一氧化氮供体氟喹诺酮/肟类化合物的合成与抗菌评价。
Arch Pharm (Weinheim). 2021 Jan;354(1):e2000180. doi: 10.1002/ardp.202000180. Epub 2020 Sep 21.
6
A review on quinoline derivatives as anti-methicillin resistant (MRSA) agents.关于喹啉衍生物作为抗耐甲氧西林金黄色葡萄球菌(MRSA)药物的综述。
BMC Chem. 2020 Mar 13;14(1):17. doi: 10.1186/s13065-020-00669-3. eCollection 2020 Dec.
7
A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV.一种新型氨基噻唑喹啉肟类化合物作为潜在多靶点抗菌药物的探索:设计、合成及对微生物、DNA、HSA 和拓扑异构酶 IV 的作用评价。
Eur J Med Chem. 2019 Oct 1;179:166-181. doi: 10.1016/j.ejmech.2019.06.046. Epub 2019 Jun 19.
8
Towards anticancer fluoroquinolones: A review article.迈向抗癌氟喹诺酮类药物:综述文章。
Arch Pharm (Weinheim). 2019 Jul;352(7):e1800376. doi: 10.1002/ardp.201800376. Epub 2019 Jun 19.
9
Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?氟喹诺酮类药物的结构和医药研发进展(2013-2018):我们现在在哪里?
Bioorg Med Chem. 2019 Jul 15;27(14):3005-3060. doi: 10.1016/j.bmc.2019.05.038. Epub 2019 May 31.
10
Identifying Novel Anti-Osteoporosis Leads with a Chemotype-Assembly Approach.运用化学型组装方法鉴定新型抗骨质疏松先导化合物。
J Med Chem. 2019 Jun 27;62(12):5885-5900. doi: 10.1021/acs.jmedchem.9b00517. Epub 2019 Jun 7.